@article{1dcb2675bb624cc398649549b50bbcad,
title = "A reassortant bunyavirus isolated from acute hemorrhagic fever cases in Kenya and Somalia",
abstract = "In late 1997 and early 1998, a large outbreak of hemorrhagic fever occurred in East Africa. Clinical samples were collected in Kenya and southern Somalia, and 27 of 115 (23%) hemorrhagic fever patients tested showed evidence of acute infection with Rift Valley fever (RVF) virus as determined by IgM detection, virus isolation, detection of virus RNA by reverse transcription-polymerase chain reaction (RT-PCR), or immunohistochemistry. However, two patients (one from Kenya and the other from Somalia) whose illness met the hemorrhagic fever case definition yielded virus isolates that were not RVF. Electron microscopy suggested these two virus isolates were members of the family Bunyaviridae. RT-PCR primers were designed to detect bunyavirus RNA in these samples. Regions of the S and L segments of the two isolates were successfully amplified, and their nucleotide sequences exhibited nearly complete identity with Bunyamwera virus, a mosquito-borne virus not previously associated with severe human disease. Unexpectedly, the virus M segment appeared to be reassorted, as the sequences detected exhibited 32-33% nucleotide and 28% amino acid differences relative to the corresponding M segment sequence of Bunyamwera virus. The association of this reassortant bunyavirus, proposed name Garissa virus, with severe disease is supported by the detection of the virus RNA in acute-phase sera taken from 12 additional hemorrhagic fever cases in the region.",
author = "Bowen, {Michael D.} and Trappier, {Sam G.} and Sanchez, {Angela J.} and Meyer, {Richard F.} and Goldsmith, {Cynthia S.} and Zaki, {Sherif R.} and Dunster, {Lee M.} and Peters, {C. J.} and Ksiazek, {Thomas G.} and Nichol, {Stuart T.}",
note = "Funding Information: We express our thanks to all of the individuals and organizations that participated in the investigation of this large hemorrhagic fever outbreak in East Africa in 1997–1998 and made possible the study pre- sented here. The international RVF Task Force included WHO, Geneva, Switzerland; WHO African Regional Office, Kenya and Somalia; Kenyan Ministries of Health and Agriculture; African Medical and Research Foundation, Nairobi, Kenya; Centers for Disease Control and Prevention; U.K. Department for International Development (DFID); Echo-Terra; EpiCentre; European Programme for Intervention Epidemiology Training (EPIET); Food and Agriculture Organization (FAO); International Committee of the Red Cross and International Federation of Red Cross and Red Crescent Societies; Kenya Medical Research Institute; M{\'e}-decins du Monde; M{\'e}decins sans Fronti{\`e}res; National Institute of Virology, Johannesburg, South Africa; Somalia Aid Coordination Body– Somalia; Swiss Disaster Relief; Terra Nova; United Nations Children{\textquoteright}s Fund (UNICEF), Nairobi, Kenya; Office of Foreign Disaster Assistance of U.S. Agency for International Development; U.S. Army Medical Research Unit–Kenya; V{\'e}t{\'e}rinaires Sans Fronti{\`e}res; and World Vision– Kenya.",
year = "2001",
doi = "10.1006/viro.2001.1201",
language = "English (US)",
volume = "291",
pages = "185--190",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "2",
}